newsfilter
← Latest News
PR Newswire·

Pulmatrix Announces Second Quarter 2023 Financial Results and Provides Corporate Update

Subject enrollment for the Phase 2b study of PUR1900 is ongoing with five additional sites added during Q2, totaling thirteen active sites to date in four countries, and topline data anticipated in Q3 2024 Submitted an